Inhaled Nitric Oxide Market to Grow with a CAGR of 7.12% through 2028
Growing neonatal
respiratory disorders is expected to drive the Global Inhaled Nitric Oxide
Market growth in the forecast period, 2024-2028
According to
TechSci Research report, “Inhaled Nitric Oxide Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2028”,
the Global Inhaled Nitric Oxide Market stood at USD 732.12 million in 2022 and
is anticipated to grow with a CAGR of 7.12% in the forecast period, 2024-2028. One
of the primary drivers fueling the growth of the global inhaled nitric oxide
market is the rising prevalence of respiratory disorders. Conditions such as
chronic obstructive pulmonary disease (COPD), asthma, and acute respiratory
distress syndrome (ARDS) have witnessed a surge in incidence globally. Inhaled
nitric oxide, with its vasodilatory and anti-inflammatory properties, has
emerged as a crucial therapeutic option for managing these respiratory
conditions. As the burden of respiratory diseases continues to escalate, the
demand for effective and targeted treatments, including inhaled nitric oxide,
is expected to rise, propelling market growth.
The application
of inhaled nitric oxide in neonatology is another significant driver shaping
the market landscape. Neonatal care has witnessed a paradigm shift with the
adoption of inhaled nitric oxide for treating persistent pulmonary hypertension
in newborns. This life-threatening condition can lead to significant morbidity
and mortality if left untreated. Inhaled nitric oxide acts as a selective
pulmonary vasodilator, improving oxygenation and reducing the need for more
invasive interventions. The expanding use of inhaled nitric oxide in neonatal
care is a critical driver for market growth, as healthcare providers
increasingly recognize its efficacy in improving outcomes for newborns.
Moreover, the
ongoing research and development activities in the field of inhaled nitric
oxide contribute substantially to market expansion. Pharmaceutical companies
are investing heavily in exploring novel applications and formulations to
broaden the therapeutic scope of inhaled nitric oxide. Clinical trials are
underway to assess its effectiveness in addressing conditions beyond
respiratory disorders, including its potential application in cardiovascular
diseases. The dynamic nature of these research initiatives fosters innovation,
with the aim of improving patient outcomes and expanding the market's reach.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Inhaled Nitric Oxide Market”
The Global
Inhaled Nitric Oxide Market is segmented into Type, End-User,
Regional Distribution, And Company.
Based on the
Product Type, Delivery Systems emerged as the dominant segment in the global
market for Global Inhaled Nitric Oxide in 2022. The versatility of delivery
systems allows for their application in diverse healthcare settings, ranging
from hospitals and clinics to home-based care. Patients with chronic
respiratory conditions may require long-term or intermittent use of inhaled
nitric oxide, making user-friendly and efficient delivery systems crucial for
their adherence to treatment plans. The convenience and ease of use associated
with these systems contribute significantly to patient compliance and,
consequently, the overall effectiveness of inhaled nitric oxide therapies. The
demand for delivery systems is driven by the need for precise dosing and
administration of inhaled nitric oxide in various clinical settings. Different
medical conditions, such as respiratory and cardiovascular disorders, require
specific dosages of inhaled nitric oxide for optimal therapeutic outcomes.
Delivery systems, including inhalation devices and associated technologies,
enable healthcare providers to accurately control the dosage and delivery of
inhaled nitric oxide, ensuring that patients receive the appropriate amount of
the therapeutic gas.
Based
on the Application, Neonatal Respiratory Treatment emerged as the dominant
segment in the global market for Global Inhaled Nitric Oxide Market in
2022. The widespread adoption of inhaled
nitric oxide in neonatal care is driven by its efficacy in improving outcomes
for infants with respiratory distress syndrome and persistent pulmonary
hypertension. It provides a non-invasive and relatively safe intervention
compared to more invasive treatments, making it particularly suitable for the
fragile and vulnerable neonatal population. Moreover, the neonatal respiratory
application of inhaled nitric oxide aligns with the global emphasis on
improving neonatal healthcare and reducing neonatal mortality rates. As
healthcare systems worldwide focus on enhancing perinatal care, the demand for
effective interventions such as inhaled nitric oxide in neonatal respiratory
treatment continues to grow. Inhaled nitric oxide acts as a selective pulmonary
vasodilator, helping to relax blood vessels in the lungs and improve oxygenation.
This targeted therapeutic approach is crucial in treating persistent pulmonary
hypertension, which can lead to hypoxemia and compromise the overall health of
newborns.
North
America emerged as the dominant player in the Global Inhaled Nitric Oxide Market
in 2022, holding the largest market share. North America, comprising the
United States and Canada, has historically been at the forefront of healthcare
innovation and has a well-established healthcare infrastructure. These factors
often contribute to the region's leadership in the adoption and utilization of
advanced medical treatments and therapies. Several factors may contribute to
North America's dominance in the inhaled nitric oxide market. The region has a
high prevalence of respiratory disorders, and the demand for effective
treatments, including inhaled nitric oxide, is likely to be substantial.
Moreover, the presence of key market players, ongoing research and development
activities, and favorable reimbursement policies in North America can
contribute to its leading position in the market.
Major companies
operating in Global Inhaled Nitric Oxide Market are:
- Abbott Laboratories
Inc
- F. Hoffmann-La Roche Ltd
- LifeScan IP
Holdings, LLC
- i-SENS, Inc.
- Ascensia Diabetes
Care Holdings AG
- AgaMatrix,
Elektronika Sales Pvt Ltd.
- Universal Biosensors
- TaiDoc Technology
Corporation
- B. Braun Melsungen
AG
Download Free Sample Report
Customers can
also request for 10% free customization
on this report
“The
Global Inhaled Nitric Oxide Market is poised for robust growth in the coming
years. The rising prevalence of respiratory disorders, including chronic
obstructive pulmonary disease (COPD) and asthma, is expected to fuel the demand
for inhaled nitric oxide therapies. Additionally, the expanding applications of
iNO in neonatal care, acute respiratory distress syndrome, and beyond, as
evidenced by ongoing research, are broadening its therapeutic scope. The global
healthcare landscape's continued focus on personalized medicine and precision
therapeutics aligns favorably with inhaled nitric oxide's versatility,
contributing to its widespread adoption. Moreover, advancements in drug
delivery systems and the integration of telehealth and remote patient monitoring
are enhancing the accessibility and efficiency of iNO treatments.” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Inhaled
Nitric Oxide Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2018-2028 Segmented By Product Type (Gas, Delivery Systems), By
Application (Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory
Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, Other
Applications) Region and Competition”, has evaluated
the future growth potential of Global Inhaled Nitric Oxide Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Inhaled Nitric Oxide Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com